TerminatedNot Applicable

Combined Effect of tDCS and Motor or Cognitive Activity in Patients With Alzheimer's Disease

Stopped: The study was interrupted before reaching the planned sample size due to the SARS-CoV-2 pandemic.

Italy23 participantsStarted 2018-06-01

Plain-language summary

The goal of this clinical trial is to evaluate the effectiveness of combining tDCS with motor or cognitive activities on cognitive functions in patients with AD. Second aim is to investigate if tDCS has a different impact if it is combined with motor or cognitive activities.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mini Mental State Examination (MMSE) major or equal to 15; * good level of compliance; * acetylcholinesterase inhibitor treatment (e.g., donepezil, rivastigmine); * no modifications of medication during the last four months. Exclusion Criteria: * behavioral disorders (e.g., aggressiveness); * alcohol abuse; * orthopedic pathology with risk of falls to the ground; * respiratory pathology; * severe auditory or visual deficits uncorrected; * history of epileptic fits; * anti-epileptic medication; * metallic body implants; pacemaker; * psychiatric, neurologic, systemic or metabolic disorders.

What they're measuring

Mini Mental State Examination (MMSE)

Timeframe: From enrollment to the end of treatment at two weeks

Trial details

NCT IDNCT06619795

SponsorUniversita di Verona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Alzheimer Disease (AD) trials